Please assess the completion status of the following clinical trial:

Trial Title: Novel Blood Test to Predict Safe Foods for Infants and Toddlers With Food Protein-induced Enterocolitis Syndrome (FPIES)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of FPIES~* Have to have documented reactions to 2-3 trigger foods with recurrent delayed vomiting or documented reactions to 4 or more trigger foods with recurrent delayed vomiting.~Exclusion Criteria:~* Patients who are currently on medications that suppress the immune system~* Patients who do not have at least 2 trigger foods identified.~* Patients who have a history of an organic Gastrointestinal (GI) disease (e.g., inflammatory bowel disease, celiac disease, biliary disorders, bowel resection), cardiac, pulmonary, neurologic, renal, endocrine, or gynecological pathology~* Lack of parental or guardian informed consent.

- Gender: ALL
- Minimum Age: 1 Month
- Maximum Age: 7 Years
- Healthy Volunteers: f

Study Arms:
- Blood test with assays (Type: EXPERIMENTAL): 10 participants with FPIES exhibiting reactions to more than 2 foods will be recruited.

Based on this trial design, predict the completion outcome and termination type (if applicable).